(Q37895908)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21716278%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

review article

1 reference

title

Biomarkers of over-immunosuppression (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21716278%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

0 references

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21716278%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

author name string

M Matz

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21716278%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

M Dürr

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21716278%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

P Glander

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21716278%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

language of work or name

English

0 references

publication date

29 June 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21716278%20AND%20SRC:MED&resulttype=core&format=json

Clinical Pharmacology & Therapeutics

6 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21716278%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

volume

90

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21716278%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21716278%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

page(s)

316-322

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21716278%20AND%20SRC:MED&resulttype=core&format=json

Biomarkers and surrogate endpoints: preferred definitions and conceptual framework

6 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.111

Biomarkers and surrogate endpoints in renal transplantation: present status and considerations for clinical trial design

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.111

Infection in solid-organ transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.111

Malignancy after renal transplantation: the role of immunosuppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.111

Managing cancer risk and decision making after kidney transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.111

Tolerance assays: measuring the unknown

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.111

What can we learn from the transcriptional characterization of spontaneously tolerant transplant recipients?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.111

Lymphocyte markers and prediction of long-term renal allograft acceptance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.111

Can we use biomarkers and functional assays to implement personalized therapies in transplantation?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.111

Biomarkers of the immunomodulatory effect of immunosuppressive drugs in transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.111

Biomarkers as a tool for management of immunosuppression in transplant patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.111

Post-transplant monitoring of renal allografts: are we there yet?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.111

Effect of long-term immunosuppression in kidney-graft recipients on cancer incidence: randomised comparison of two cyclosporin regimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.111

Target enzyme activity as a biomarker for immunosuppression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.111

Prolonged CD4 T cell lymphopenia increases morbidity and mortality after renal transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.111

Pharmacodynamic monitoring of calcineurin inhibitor therapy: is there a clinical benefit?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.111

Pharmacodynamic monitoring of calcineurin inhibition therapy: principles, performance, and perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.111

Gene expression analysis of calcineurin isoforms in T-lymphocytes--a method applied on kidney-transplant recipients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.111

Monitoring antitumor efficacy of rapamycin in Kaposi sarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.111

Distinct immunohistochemical phenotype of nonmelanoma skin cancers between renal transplant and immunocompetent populations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.111

A spectrophotometric assay for routine measurement of mammalian target of rapamycin activity in cell lysates

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.111

Genetic polymorphisms and the fate of the transplanted organ

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.111

Pharmacogenetics in solid organ transplantation: current status and future directions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.111

A comprehensive genotype-phenotype interaction of different Toll-like receptor variations in a renal transplant cohort.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.111

ABCB1 genotypes predict cyclosporine-related adverse events and kidney allograft outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.111

Evidence for genetic susceptibility towards development of posttransplant lymphoproliferative disorder in solid organ recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.111

International consensus guidelines on the management of cytomegalovirus in solid organ transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.111

Cell-mediated immunity to predict cytomegalovirus disease in high-risk solid organ transplant recipients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.111

A prospective longitudinal analysis of cytomegalovirus (CMV)-specific CD4+ and CD8+ T cells in kidney allograft recipients at risk of CMV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.111

Pre-transplant soluble CD30 level as a predictor of not only acute rejection and graft loss but pneumonia in renal transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.111

Immune phenotype predicts risk for posttransplantation squamous cell carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.111

Benefit of immune monitoring in heart transplant patients using ATP production in activated lymphocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.111

Reduction in cardiovascular death after kidney transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.111

7 January 2021

BK virus in solid organ transplant recipients

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.111

7 January 2021

Tolerance versus immunosuppression: a perspective

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.111

7 January 2021

Long-term kinetic of T-lymphocyte subsets in kidney-transplant recipients: influence of anti-T-cell antibodies and association with posttransplant malignancies

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.111

7 January 2021